FDA Inspection 683673 — Molecular Imaging Program At Stanford

Molecular Imaging Program At Stanford — FEI 3005712028

The FDA completed an inspection of Molecular Imaging Program At Stanford on Oct 6, 2010 in Palo Alto, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.